Chronic Heart Failure
Conditions
Keywords
Heart failure, Hospitalization, Pneumococcal vaccination
Brief summary
Heart failure affects more than 1.5 million people in France, resulting in over 70,000 deaths and more than 165,000 hospitalizations each year. Viral and bacterial infections are frequently associated with episodes of acute heart failure in patients with chronic heart failure (CHF). Lower respiratory tract infections, such as influenza and pneumococcus, are common causes of hospitalization for decompensated heart failure, leading to increased morbidity and mortality. Studies have shown that pneumococcal vaccination can reduce the risks of heart attack or stroke in patients with heart failure. However, despite vaccination recommendations, coverage rates remain low, especially for pneumococcus. In this study, we will evaluate the impact of an incentive letter for pneumococcal vaccination on one-year hospitalization rate in patients with heart failure.
Interventions
Incentive letter for pneumococcal vaccination to the patient and to the GP
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patients over 45 * Residing in the Occitanie region, France * With heart failure registered as ALD * Who have declared an attending physician * Who have not received a pneumococcal vaccination for more than 24 months (due to the length of time available in the database)
Exclusion criteria
-None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year Pneumococcus vaccination rate | at 1-year |
Secondary
| Measure | Time frame |
|---|---|
| 1-year all-cause hospital admission rate | at 1-year |
| 1-year specific hospital admission rate | at 1-year |
| 1-year all-cause mortality rate | at 1-year |
Countries
France